The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-Amino-3-(hydroxy-{3-[3-(4-undecyloxy-phenyl)-propionyloxy]-propoxy}-phosphoryloxy)-propionic acid ID: ALA3577181
PubChem CID: 122177527
Max Phase: Preclinical
Molecular Formula: C26H44NO9P
Molecular Weight: 545.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCOc1ccc(CCC(=O)OCCCOP(=O)(O)OC[C@H](N)C(=O)O)cc1
Standard InChI: InChI=1S/C26H44NO9P/c1-2-3-4-5-6-7-8-9-10-18-33-23-15-12-22(13-16-23)14-17-25(28)34-19-11-20-35-37(31,32)36-21-24(27)26(29)30/h12-13,15-16,24H,2-11,14,17-21,27H2,1H3,(H,29,30)(H,31,32)/t24-/m0/s1
Standard InChI Key: LSCJPEVNUYGUBE-DEOSSOPVSA-N
Molfile:
RDKit 2D
37 37 0 0 0 0 0 0 0 0999 V2000
5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1873 -7.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4855 -8.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4833 -9.7656 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7815 -10.5187 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
7.7794 -12.0195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8218 -9.9205 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7838 -9.3187 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0776 -12.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0755 -14.2734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3737 -15.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0352 -14.8716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9336 -3.1588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4140 -14.4283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3720 -16.2265 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4990 0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8003 1.4887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0990 0.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.4003 1.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6990 0.7318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.0003 1.4796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2989 0.7273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.6002 1.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.6386 0.8736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 1 0
5 8 2 0
6 9 1 0
9 10 1 0
10 11 1 0
10 12 1 1
13 14 1 0
13 15 1 0
15 16 1 0
17 16 1 0
13 18 2 0
11 19 1 0
11 20 2 0
17 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 17 1 0
23 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 545.61Molecular Weight (Monoisotopic): 545.2754AlogP: 5.01#Rotatable Bonds: 23Polar Surface Area: 154.61Molecular Species: ZWITTERIONHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.58CX Basic pKa: 9.38CX LogP: 3.44CX LogD: 0.36Aromatic Rings: 1Heavy Atoms: 37QED Weighted: 0.10Np Likeness Score: 0.41
References 1. Ikubo M, Inoue A, Nakamura S, Jung S, Sayama M, Otani Y, Uwamizu A, Suzuki K, Kishi T, Shuto A, Ishiguro J, Okudaira M, Kano K, Makide K, Aoki J, Ohwada T.. (2015) Structure-activity relationships of lysophosphatidylserine analogs as agonists of G-protein-coupled receptors GPR34, P2Y10, and GPR174., 58 (10): [PMID:25970039 ] [10.1021/jm5020082 ]